15 results on '"De Boer, R.H."'
Search Results
2. Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)
3. 205P Pooled exploratory analysis of survival in patients (pts) with HR+/HER2- advanced breast cancer (ABC) and visceral metastases (mets) treated with ribociclib (RIB) + endocrine therapy (ET) in the MONALEESA (ML) trials
4. VP5-2021: IMpower133: Gene expression (GE) analysis in long-term survivors (LTS) with ES-SCLC treated with first-line carboplatin and etoposide (CE) ± atezolizumab (atezo)
5. A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer
6. Multimodality therapy in inflammatory breast cancer: Is there a place for surgery?
7. Continuous infusional combination chemotherapy in inflammatory breast cancer: a phase II study
8. A Phase 2, Randomized, Double-Blind, Multicenter Trial of Denosumab in Combination with Chemotherapy As First-Line Treatment of Metastatic Non-Small Cell Lung Cancer
9. Risk Factors for Hypocalcemia in Patients with Cancer Receiving Denosumab
10. AOSOP6 Results from the 2-year open-label extension treatment phase of a pivotal phase 3 study of denosumab in patients with breast cancer and bone metastases previously treated with zoledronic acid or denosumab
11. 412 BMS-754807, an oral dual IGF-1R/insulin receptor (IR) inhibitor: initial results from a Phase 1 dose- and schedule-finding study in combination with carboplatin/paclitaxel in subjects with solid tumors
12. 9004 Vandetanib plus pemetrexed vs pemetrexed as 2nd-line therapy in patients with advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial
13. 1513P - Risk Factors for Hypocalcemia in Patients with Cancer Receiving Denosumab
14. 1330TiP - A Phase 2, Randomized, Double-Blind, Multicenter Trial of Denosumab in Combination with Chemotherapy As First-Line Treatment of Metastatic Non-Small Cell Lung Cancer
15. Pegylated Recombinant Megakaryocyte Growth and Development Factor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.